References
- Kindt TJ, Goldsby RA, Osborne BA. Kuby Immunology (2007). New York: Freeman, W.H. and Co; 2007.
- GOWANS JL. The effect of the continuous re-infusion of lymph and lymphocytes on the output of lymphocytes from the thoracic duct of unanaesthetized rats. Br J Exp Pathol. 1957;38:67–78.
- HALL JG, MORRIS B. The origin of the cells in the efferent lymph from a single lymph node. J Exp Med. 1965;121:901–10. doi:https://doi.org/10.1084/jem.121.6.901.
- Szabo PA, Miron M, Farber DL. Location, location, location: tissue resident memory T cells in mice and humans. Sci Immunol. 2019;4:eaas9673. doi:https://doi.org/10.1126/sciimmunol.aas9673.
- Duijvestijn A, Hamann A. Mechanisms and regulation of lymphocyte migration. Immunol Today. 1989;10:23–28. doi:https://doi.org/10.1016/0167-5699(89)90061-3.
- Mackay CR, Marston WL, Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med. 1990;171:801–17. doi:https://doi.org/10.1084/jem.171.3.801.
- Westermann J, Ehlers E-M, Exton MS, Kaiser M, Bode U. Migration of naive, effector and memory T cells: implications for the regulation of immune responses. Immunol Rev. 2001;184:20–37. doi:https://doi.org/10.1034/j.1600-065x.2001.1840103.x.
- Cyster JG, Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol. 2012;30:69–94. doi:https://doi.org/10.1146/annurev-immunol-020711-075011.
- Klonowski KD, Marzo AL, Williams KJ, Lee S-J, Pham Q-M, Lefrançois L. CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen. J. Immunol. 2006;177(6738):LP–6746. doi:https://doi.org/10.4049/jimmunol.177.10.6738.
- Olson MR, McDermott DS, Varga SM. The initial draining lymph node primes the bulk of the CD8 T cell response and influences memory T cell trafficking after a systemic viral infection. PLoS Pathog. 2012;8:e1003054. doi:https://doi.org/10.1371/journal.ppat.1003054.
- Hunter MC, Teijeira A, Halin C. T cell trafficking through lymphatic vessels. Front Immunol. 2016;7:613. doi:https://doi.org/10.3389/fimmu.2016.00613.
- Wiedle G, Dunon D, Imhof BA. Current concepts in lymphocyte homing and recirculation. Crit Rev Clin Lab Sci. 2001;38:1–31. doi:https://doi.org/10.1080/20014091084164.
- Perfetto SP, Ambrozak D, Nguyen R, Chattopadhyay P, Roederer M. Quality assurance for polychromatic flow cytometry. Nat Protoc. 2006;1:1522–30. doi:https://doi.org/10.1038/nprot.2006.250.
- Fuertes Marraco SA, Bovay A, Nassiri S, Maby-El Hajjami H, Ouertatani-Sakouhi H, Held W, Speiser DE. The human CD8 T stem cell-like memory phenotype appears in the acute phase in Yellow Fever virus vaccination. Biorxiv. 2019;808774. doi: https://doi.org/10.1101/808774
- Bovay A, Nassiri S, Maby–El Hajjami H, Marcos Mondéjar P, Akondy RS, Ahmed R, Lawson B, Speiser DE, Fuertes Marraco SA. Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies. Vaccine. 2020;38(9):2172–82. doi:https://doi.org/10.1016/j.vaccine.2020.01.045.
- Kohler S, Bethke N, Böthe M, Sommerick S, Frentsch M, Romagnani C, Niedrig M, Thiel A. The early cellular signatures of protective immunity induced by live viral vaccination. Eur J Immunol. 2012;2363–73. doi:https://doi.org/10.1002/eji.201142306.
- Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708–12. doi:https://doi.org/10.1038/44385.
- Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745–63. doi:https://doi.org/10.1146/annurev.immunol.22.012703.104702.
- Nolz JC, Health IO. Biology, C. & Health, O. HHS Public Access. 2016;72:2461–73.
- Tomura M, Itoh K, Kanagawa O. Naive CD4+ T lymphocytes circulate through lymphoid organs to interact with endogenous antigens and upregulate their function. J Immunol. 2010;184(4646):LP–4653. doi:https://doi.org/10.4049/jimmunol.0903946.
- Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 2002;277:21453–57. doi:https://doi.org/10.1074/jbc.C200176200.
- Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 2002;296(5566):346–9. doi:https://doi.org/10.1126/science.1070238.
- Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, Vedrine C, Kristofic C, Kuhle J, Lindberg RLP, Kappos L, et al. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology. 2008;71(1261):LP–1267. doi:https://doi.org/10.1212/01.wnl.0000327609.57688.ea.
- Mehling M, Johnson TA, Antel J, Kappos L, Bar-Or A. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. Neurology. 2011;76:S20 LP–S27. doi:https://doi.org/10.1212/WNL.0b013e31820db341.
- Kappos L, Antel J, Comi G, Montalban X, O’Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N. Engl. J. Med. 2006;355:1124–40. doi:https://doi.org/10.1056/NEJMoa052643.
- Brinkmann V, Lynch KR. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol. 2002;14:569–75. doi:https://doi.org/10.1016/S0952-7915(02)00374-6.
- Han S, Zhang X, Wang G, Guan H, Garcia G, Li P, Feng L, Zheng B. FTY720 suppresses humoral immunity by inhibiting germinal center reaction. Blood. 2004;104:4129–33. doi:https://doi.org/10.1182/blood-2004-06-2075.
- Winkelmann A, Loebermann M, Reisinger EC, Hartung H-P, Zettl UK. Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol. 2016;12:217–33. doi:https://doi.org/10.1038/nrneurol.2016.21.
- Grebenciucova E, Reder AT, Bernard JT Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature. Mult. Scler. Relat. Disord. 9, 158–62 (2016).
- SAGE Working Group. Background paper on Yellow Fever vaccine. WHO. 2013. http://www.who.int/immunization/sage/previous/en/index.html
- WHO. Vaccines and vaccination against yellow fever: WHO position paper, June 2013—Recommendations. Vaccine. 2015;33:76–77. doi:https://doi.org/10.1016/j.vaccine.2014.05.040.
- Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, Kurane I, Rothman AL, Ennis FA. Early CD69 Expression on Peripheral Blood Lymphocytes from Children with Dengue Hemorrhagic Fever. J Infect Dis. 1999;1429–35. doi:https://doi.org/10.1086/315072.
- Lingblom CMD, Kowli S, Swaminathan N, Maecker HT, Lambert SL. Baseline immune profile by CyTOF can predict response to an investigational adjuvanted vaccine in elderly adults. J Transl Med. 2018;16:153. doi:https://doi.org/10.1186/s12967-018-1528-1.